UAB Biotechnologinės farmacijos centras "Biotechpharma"
Copy
Copy
CopyCompany details
Legal status
ActiveCompany ID
300041719Copy
CopyVAT code
LT100001266014Copy
CopyFrom 05/11/2004
Incorporation date
16/07/2004Company's manager/representative
Vladas Algirdas Bumelis, Director GeneralCopy
CopyShare capital
1,241,022.88 EURActivity
Research and experimental development on other natural sciences and engineering (72.10.90 - EVRK 2.1)Contacts
Company registration address
Vilnius, Mokslininkų g. 4, LT-08412Check the map
Copy
-
Pre-Score is a statistical predictive model developed by our partner, SCORIFY, based on open data about legal entities. Pre-Score predicts the probability of a company's bankruptcy within next 12 months. Based on all available data about the company (not only open data), the probability of default is estimated by SCORIFY's GOscore rating, which can be found in credit report.Important: The Pre-Score is an opinion of SCORIFY, expressed by using a defined and specified assessment scale. SCORIFY's opinion is not necessarily the same as the opinion of creditors or the company's about its financial reliability.
More about SCORIFY www.scorify.ai
B
HighHighest reliabilityLowest reliability
Reliability
A - Highest
B - HighC - Average
D - Low
E - Lowest
Fair Business loans
Borrow for business up to 50 000 € without collateralApply for a loan
Data on insured persons (natural persons) whose state social insurance commencement has been notified by the employer to the SSIFB.More information: www.sodra.lt
Number of employees
108
-1 ** during past year
The average wage - the amount of wages or other income on which social security contributions are paid. This data is disclosed only if company has more than 3 employees.Average wage
4,028.47 €
3,770.68 €
4,332.08 €
+51.64 € ** during past year
Debts
0.00 €
0 € ** during past year
-20 %Turnover
74,035,286 €Credit report
25
Data sourcesBusiness linkages
10
LinkagesMonitoring
72
Changes during the yearSimilar companies
4
Similar companiesThe value of a company is calculated by our partner UAB SCORIFY and is based on Excess return model. It measures the ability of business to generate value added profit in both - short and long term.The calculations of Escess return model use main profitability and growth ratios, that are also assessed by analyzing company`s financial state.
Company`s value helps:
- Find out if your business has paid off.
- Compare the value of your, competitor`s or business partners companies.
- Strengthen the negotiating position in case of purchase or sale of the company.
More about SCORIFY www.scorify.ai
Company's value
Register and
explore Okredo dataCredit limit is a product of our partner, credit risk assessment and artificial intelligence professional company SCORIFY. The credit limit calculation is based on financial statement data provided by company to Register of Legal Entities and statistical credit risk assessment model of GO score - UAB SCORIFY. Main financial ratios used in calculation of credit limit are:
- Tangible assets.
- Working capital.
- Sales.
- Efficiency ratios.
- Profitability ratios.
- Liquidity ratios.
Credit limit will help you:
- Preliminary assess your credit options before applying for a loan or buying a assets by lease (eg equipment or a car).
- Quickly and easily assess the financial capabilities of business partners by selling them goods or services on deferred payment.
More about SCORIFY www.scorify.ai
Credit limit
EstimatedUAB Biotechnologinės farmacijos centras "Biotechpharma" related persons
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Vladas Algirdas Bumelis | Director General | 02/12/2020 | - | 55 |
UAB Biotechnologinės farmacijos centras "Biotechpharma" financial ratios
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€)From 2022 the financial data of public bodies, associations and charities and support funds shows the total income, which is the sum of sales income, financing income and all other income. |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirementThe working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2022 |
|---|
| 123,919,188 |
| 709,651 |
| 60,120,244 |
| 60,120,244 |
| 344,292 |
| 56.37 |
| 48.52 |
| 97,117,629 |
| 58,745,860 |
| 85,544,582 |
| 82,060,375 |
| 2023 |
|---|
| 93,045,600 |
| 575,670 |
| 50,779,570 |
| 50,779,570 |
| 314,172 |
| 63.31 |
| 54.57 |
| 94,214,496 |
| 61,164,150 |
| 56,086,298 |
| 110,169,310 |
| 2024 |
|---|
| 74,035,286 |
| 641,220 |
| 45,581,203 |
| 45,581,203 |
| 394,779 |
| 56.33 |
| 61.57 |
| 114,940,959 |
| 61,271,818 |
| 83,999,105 |
| 102,556,891 |
Register and
explore Okredo data| 2024 |
|---|
| 74,035,286 |
| 641,220 |
| 45,581,203 |
| 45,581,203 |
| 394,779 |
| 56.33 |
| 61.57 |
| 114,940,959 |
| 61,271,818 |
| 83,999,105 |
| 102,556,891 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
74,035,286 €
-20 % *
Sales per employee (€)
641,220 €
11 % *
Profit before tax (€)
45,581,203 €-10 % *
Net Profit (€)
45,581,203 €-10 % *
Profit per employee (€)
394,779 €26 % *
Total profitability (%)
56.33 %-11.03 % *
Net profitability (%)
61.57 %12.83 % *
Equity (€)
114,940,959 €22 % *
Amounts Payable And Liabilities (€)
61,271,818 €
0 % *
Non-current Assets (€)
83,999,105 €50 % *
CurrentAssets (€)
102,556,891 €
-7 % *
Credit history
No. of unpaid debts
Register and
explore Okredo dataAmount of unpaid debts
Register and
explore Okredo dataCredit report
Price: €35.99
Premium users: 1.00 credit
Premium users: 1.00 credit
Company has debt ?
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Unpaid debts
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Debts payment history
Creditor/Data source | Debt amount | Debt date / Payment date | Debt type |
|---|---|---|---|
- | - | - | - |
Tax debtsSODRA debt is the amount of national social security contributions, fines, late payment penalties and interest that company should have been paid in accordance with the legislation 2 working days before the date of debt public disclosure. Deferred debt is a debt for which the due date has been postponed in accordance with the procedure provided for by law and has not yet expired. Debts is updated only on working days, except for the first working day after the public holiday.
SODRA debt is the amount of national social security contributions, fines, late payment penalties and interest that company should have been paid in accordance with the legislation 2 working days before the date of debt public disclosure. Deferred debt is a debt for which the due date has been postponed in accordance with the procedure provided for by law and has not yet expired. Debts is updated only on working days, except for the first working day after the public holiday.
Sodra debt
STI debtCourts
Defendant
(0)
Plaintiff
(1)
3rd party
(0)
Cases (Company as defendant)
0
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Cases (Company as plaintiff)
1
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
30/10/2024e2-2098-803/20242-55-3-00518-2024-7 | Plaintiff:UAB Biotechnologinės farmacijos centras "Biotechpharma" Defendant:ISR Immune System Regulation | Reason: Dėl skolos priteisimo Decision: Ieškinys patenkintas (visiškai) | Vilniaus apygardos teismas | 3 |  |
Cases (Company as third party)
0
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
ESG data
Energy performance of the company's head office building
Information is provided on the basis of public data about building energy efficiency certification published by State Agency of Construction Sector Development.More information: https://www.ssva.lt
Energy efficiency
B
AddressVilnius, Mokslininkų g. 4, LT-08412
Certificate No.MK-0550-00011
Date of issue03/11/2020
Valid till03/11/2030
Heated area4058.7 m²
Heat sourceŠil.šaltinis_1: Šilumos tinklai + centrinis šilumos punktas
Energy consumptionEnergy consumption (kWh/m²/year) - Calculated total energy consumption per square metre of the useful floor area of a building (part of a building).
0 kWh/m²/metaiEnergy consumption (kWh/m²/year) - Calculated total energy consumption per square metre of the useful floor area of a building (part of a building).Co2 emissionCO₂ - the annual carbon dioxide emissions of a building (part of a building).
9.08 kg/m²/metaiCO₂ - the annual carbon dioxide emissions of a building (part of a building).Energy consumption for heating
36.51 kWh/m²/metaiBuilding function
Mokslo paskirties pastataiEnergy effiency class
BVehicles
5
The data is provided only on vehicles that company owns by the right of owner operator or owner-operator. No data will be provided on vehicles that company is financing the purchase of.Company's eco score according CO² of vehicle fleet
Green Index is a unique solution developed by Okredo. This solution allows to estimate the carbon footprint of company's fleet. If WLTP/NEDC carbon footprint data is not provided, then the calculations are made using open technical data of the vehicles provided by the State Enterprise Regitra and the provisions of the Law on Motor Vehicle Registration Tax.The highest level of climate friendlyness applies to those companies, whose vehicles emit no more than 120 g/km of CO2m per vehicle.
<120
120 - 140
140 - 155
155 - 170
170 - 190
190 - 255
255+
Not determinedMaximum environmental friendliness
Lowest environmental friendliness
Vehicles
CLASS
AMOUNT
(<120)1
(120 - 140)1
(140 - 155)0
(155 - 170)1
(170 - 190)0
(190 - 255)1
(255+)1
(Not determined)0
Total
5
Eco score | Brand, model | Category | Engine capacity | Fuel |
|---|---|---|---|---|
83.8 | BOMBARDIER RECREATIONAL PRODUCTS (BRP) CAN - AMFirst registration: 01/02/2017 | Quad bike up to 400 kg | 854.00 cm³ | Petrol |
139 | VOLKSWAGEN. VW CADDYFirst registration: 03/06/2019 | Passenger car | 1,968.00 cm³ | Diesel |
166 | VOLKSWAGEN. VW TIGUANFirst registration: 10/07/2018 | Passenger car | 1,984.00 cm³ | Petrol |
200 | MERCEDES-BENZ S 560 4MATICFirst registration: 17/08/2017 | Passenger car | 3,982.00 cm³ | Petrol |
315 | JEEP GRAND CHEROKEE SRTFirst registration: 25/07/2017 | Passenger car | 6,417.00 cm³ | Petrol |
Trademarks
Company registered trademarks
1
Trademark view | Trademark | Type | Application No | Registration No | Expire | TM status |
|---|---|---|---|---|---|---|
 | NORTHWAY BIOTECHPHARMA | Graphical | 2019 1294 | 82070 | 01/08/2029 | Registered |
Public data
Govermental support
Institution | Support measure |
|---|---|
 | Covid 19 aid measures (subsidies, compensation) in 2020 - 2022 |
| Covid 19 aid measures (guarantees provided) in 2020 - 2022 |
| Covid 19 aid measures (loans) in 2020 - 2022 |
 | Non-refundable subsidy for micro-enterprises 2020 |
| Fund of ILTE business stimulation means (2020) |
Register and
explore Okredo dataPublic negative information
Data source | Information |
|---|---|
 | Redundancy of employees group (number of employees notified, date of announcement) |
 | Tax inspectorate information on payments in cash |
 | Public procurement office information on unreliable suppliers |
| Public procurement office information on those that supplied false data |
| Public procurement office information on possible disqualification from public procurement procedures |
Register and
explore Okredo dataPublic data
Data source | Information |
|---|---|
| Top tax payers (2024 I-IIIQ). |
| Top tax payers (2024 IHY). |
| Top personal income tax payers in 2023. |
| Top personal income tax payers in 2022. |
 | Data from the B2Lithuania database of exporters |
Register and
explore Okredo dataLicenses
Licences, certificates, permits, other licensing documents
13
Registration number | Term of validity From / To | Licensing authority | Type | Species |
|---|---|---|---|---|
083/21N 2021-12-06 | 06/12/2021 / 01/01/2022 | Narkotikų, tabako ir alkoholio kontrolės departamentas | Permit | Permit to purchase undenatured ethyl alcohol |
A635-638/21(2.3.2.1E-LIC) 2021-07-09 | 09/07/2021 / 08/07/2031 | Vilniaus miesto savivaldybės administracija | Permit | Permit to install external advertising |
A635-796/20(2.3.2.1E-LIC) 2020-10-05 | 05/10/2020 / 24/10/2024 | Vilniaus miesto savivaldybės administracija | Permit | Permit to install external advertising |
A635-579/20(2.3.2.1E-LIC) 2020-08-03 | 03/08/2020 / 03/08/2025 | Vilniaus miesto savivaldybės administracija | Permit | Permit to install external advertising |
A635-580/20(2.3.2.1E-LIC) 2020-08-03 | 03/08/2020 / 03/08/2025 | Vilniaus miesto savivaldybės administracija | Permit | Permit to install external advertising |
Public procurement
No. of won tenders
0* during past yearTotal value of contracts
0 €Number of announced tenders
0* during past yearTotal value of contracts
0 €Won tenders
Date | Procurer/contractor | Amount | Project |
|---|---|---|---|
- | - | - | - |
Announced tenders
Date | Procurer/contractor | Amount | Project |
|---|---|---|---|
- | - | - | - |
Archive of articles
Data source | Article | Date |
|---|---|---|
 | ||
| ||
| ||
| ||
|
BNS News
0
Register and
explore Okredo dataSimilar companies
4
Category:
Research and development in technical sciencesComp. code:
303353414Reg. date:
22/07/2014Turnover:
20-50 M €No. of employees:
207Category:
Research and development in medical sciencesComp. code:
135750888Reg. date:
09/04/2001Turnover:
20-50 M €No. of employees:
71Category:
Research and development in natural sciencesComp. code:
111959420Reg. date:
22/04/1997Turnover:
50-100 M €No. of employees:
144Category:
Research and experimental development on social sciencesComp. code:
300654654Reg. date:
02/03/2007Turnover:
10-20 M €No. of employees:
86Description
CopyAbout UAB Biotechnologinės farmacijos centras "Biotechpharma"
UAB Biotechnologinės farmacijos centras "Biotechpharma" was established in 16/07/2004, its legal status according to data of Registry of Legal Entities is Active.Main activity of the company according NACE2 classification – Research and experimental development on other natural sciences and engineering (72.10.90 - EVRK 2.1), 72.10.90. Company is owned by 3 shareholders. Company's representation right – The rule of quantitative representation.
In 2024 UAB Biotechnologinės farmacijos centras "Biotechpharma" turnover was 74,035,286 EUR, gross profit 45,581,203 EUR. According to SODRA company has 108 employees. UAB Biotechnologinės farmacijos centras "Biotechpharma" is registered at – Vilnius, Mokslininkų g. 4, LT-08412.
Business objectives of the company as officially recorded in the Register of Legal Entities: pagrindinių vaistų pramonės gaminių bei farmacinių preparatų gamyba bei visa kita su tuo susijusi veikla ir paslaugų teikimas. Veikla: pagrindinių vaistų pramonės gaminių gamyba; farmacinių preparatų gamyba; kitų prekių mažmeninė prekyba specializuotose parduotuvėse; vaistinių, ruošiančių ir parduodančių vaistus, veikla; medicinos ir ortopedinių prekių mažmeninė prekyba; nuosavo arba nuomojamo nekilnojamojo turto nuoma ir eksploatavimas; kiti gamtos mokslų ir inžinerijos moksliniai tyrimai ir taikomoji veikla (no translation available)
All data about UAB Biotechnologinės farmacijos centras "Biotechpharma" is up to date and consistent with the primary data source.